Arne Forsgren

författare

• 2012
  • Comparing Health Outcomes and Costs of General Vaccination with Pneumococcal Conjugate Vaccines in Sweden: A Markov Model
  • Increase of beta-Lactam-Resistant Invasive Haemophilus influenzae in Sweden, 1997 to 2010
  • Increase of ss-lactam resistant invasive Haemophilus influenzae in Sweden 1997-2010.
• 2011
  • Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains
• 2010
  • Invasive disease by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains.
• 2009
  • Nontypeable Haemophilus influenzae Adhesin Protein E: Characterization and Biological Activity.
  • Nontypeable Haemophilus influenzae as a Pathogen in Children.
  • Prevention of otitis media: Now a reality?
• 2008
  • Haemophilus influenzae interacts with the human complement inhibitor factor H
  • Identification of a novel Haemophilus influenzae protein important for adhesion to epithelial cells.
  • Moraxella catarrhalis-dependent tonsillar B cell activation does not lead to apoptosis but to vigorous proliferation resulting in nonspecific IgM production.
  • Moraxella-Dependent {alpha}1-Antichymotrypsin Neutralization - A Unique Virulence Mechanism.
  • Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
  • Purification of alpha1-antichymotrypsin from human plasma with recombinant M. catarrhalis ubiquitous surface protein A1.
  • The Moraxella IgD-binding protein MID/Hag is an oligomeric autotransporter.
• 2007
  • A normally occurring staphylococcus antibody in human serum - Commentary
  • Characterization of the IgD binding site of encapsulated Haemophilus influenzae serotype b.
  • Haemophilus influenzae Survival during Complement-Mediated Attacks Is Promoted by Moraxella catarrhalis Outer Membrane Vesicles.
  • Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
• 2006
  • Haemophilus influenzae Surface Fibrils Contribute to Serum Resistance by Interacting with Vitronectin.
  • MID and UspA1/A2 of the human respiratory pathogen Moraxella catarrhalis, and interactions with the human host as basis for vaccine development.
  • Purification of IgD from human serum - A novel application of recombinant M. catarrhalis IgD-binding protein (MID).
  • Serological Response to M. catarrhalis Outer Membrane Protein MID as Compared to UspA1 and A2.
  • The IgD C(H)1 region contains the binding site for the human respiratory pathogen Moraxella catarrhalis IgD-binding protein MID.
  • The IgD-binding domain of the Moraxella IgD-binding protein MID (MID962-1200) activates human B cells in the presence of T cell cytokines.
  • The Respiratory Pathogen Moraxella catarrhalis Binds to Laminin via Ubiquitous Surface Proteins A1 and A2.
• 2005
  • Evaluation of Western Blot CagA Seropositivity in Helicobacter pylori-Seropositive and -Seronegative Subjects.
  • Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity
  • The CD19 molecule is crucial for MID-dependent activation of tonsillar B cells from children.
  • The Respiratory Pathogen Moraxella catarrhalis Adheres to Epithelial Cells by Interacting with Fibronectin through Ubiquitous Surface Proteins A1 and A2.
• 2004
  • Detection of Mycobacterium tuberculosis complex in formalin-fixed, paraffin-embedded tissue specimens with necrotizing granulomatous inflammation by strand displacement amplification
  • Immunization with the Truncated Adhesin Moraxella catarrhalis Immunoglobulin D-Binding Protein (MID764-913) Is Protective against M. catarrhalis in a Mouse Model of Pulmonary Clearance.
  • The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2
• 2003
  • Increased sensitivity of Mycobacterium tuberculosis Cobas Amplicor PCR following brief incubation of tissue samples on Löwenstein-Jensen substrate.
  • Several gene programs are induced in ciprofloxacin-treated human lymphocytes as revealed by microarray analysis.
  • The Immunoglobulin D-Binding Protein MID from Moraxella catarrhalis Is Also an Adhesin.
  • The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation.
• 2002
  • Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae.
  • Susceptibilities of Mycobacterium marinum to Gatifloxacin, Gemifloxacin, Levofloxacin, Linezolid, Moxifloxacin, Telithromycin, and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones.
  • The immunoglobulin D-binding part of the outer membrane protein MID from Moraxella catarrhalis comprises 238 amino acids and a tetrameric structure.
  • The novel IgD binding protein from Moraxella catarrhalis induces human B lymphocyte activation and Ig secretion in the presence of Th2 cytokines.
• 2001
  • Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms
  • Isolation and characterization of a novel IgD-binding protein from Moraxella catarrhalis
  • Protein D expression promotes the adherence and internalization of non-typeable Haemophilus influenzae into human monocytic cells
  • Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori-infected individuals
• 1999
  • Effects on the ciliated epithelium of protein D-producing and -nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue cultures
  • Fragmentation heterogeneity of 23S ribosomal RNA in Haemophilus species
• 1998
  • Glycerol-3-phosphate transport in Haemophilus influenzae: cloning, sequencing, and transcription analysis of the glpT gene
• 1997
  • Amoxicillin treatment of experimental acute otitis media caused by Haemophilus influenzae with non-beta-lactamase-mediated resistance to beta-lactams: aspects of virulence and treatment
  • Association between Helicobacter pylori and gastric carcinoma in the city of Malmo, Sweden. A prospective study
• 1996
  • Biological activity of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae
• 1995
  • The gene encoding protein D (hpd) is highly conserved among Haemophilus influenzae type b and nontypeable strains
• 1994
  • Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model
• 1993
  • Limited diversity of the protein D gene (hpd) among encapsulated and nonencapsulated Haemophilus influenzae strains
• 1992
  • Protein D, the immunoglobulin D-binding protein of Haemophilus influenzae, is a lipoprotein
• 1991
  • Protein D, an immunoglobulin D-binding protein of Haemophilus influenzae: cloning, nucleotide sequence, and expression in Escherichia coli
• 1989
  • Use of ciprofloxacin in patients undergoing transurethral prostatic surgery
• 1987
  • Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery
• 1986
  • Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection
• 1982
  • Enzyme-linked immunosorbent assay (ELISA) for antibodies against Campylobacter jejuni, and its clinical application